anaplastic lung cancer calu 6 Search Results


calu  (ATCC)
96
ATCC calu
Calu, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/Calu-6/10__1158_slash_1078___0432__ccr___04___1147-47-0-9
Average 96 stars, based on 1 article reviews
calu - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

90
Broad Institute Inc msigdb c2
Msigdb C2, supplied by Broad Institute Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/msigdb+c2/pmc04867636__srep26061___s1-13821-42-2
Average 90 stars, based on 1 article reviews
msigdb c2 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

sw1573  (ATCC)
95
ATCC sw1573
Sw1573, supplied by ATCC, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/SW+1573/pmc12696963-25-23-36
Average 95 stars, based on 1 article reviews
sw1573 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

99
ATCC human nsclc lines
Figure 3. A, <t>NSCLC</t> lines were grown as s.c. xenografts in nu/nu mice and dosed for 14 days with erlotinib (100 mg/kg qd) or vehicle control. Statistical evaluation of percent tumor growth inhibition by repeated measures ANOVA was <t>done.</t> <t>H292,</t> <t>H358,</t> and <t>H441</t> were found to be sensitive to EGFR inhibition in vivo. No correlation between tumor growth rate and sensitivity to EGFR inhibition was observed. Solid bars, erlotinib dosing period. B, tumor cell lysates were evaluated for the expression of epithelial and mesenchymal proteins. Tumors were grown to a volume of f300 mm3, excised, and flash frozen in liquid nitrogen. Tumor tissues were pulverized while frozen, subjected to detergent lysis and SDS-PAGE as described, and immunoblots probed with antibodies to E-cadherin, h-catenin, Brk, fibronectin, and vimentin. Similar with in vitro results, E-cadherin expression was restricted to erlotinib-sensitive lines and vimentin to insensitive lines. Antibody to GAPDH was used as a loading control.
Human Nsclc Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/A549/10__1158_slash_0008___5472__can___05___1058-34-1-27
Average 99 stars, based on 1 article reviews
human nsclc lines - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

99
ATCC cancer cell lines
Figure 3. A, <t>NSCLC</t> lines were grown as s.c. xenografts in nu/nu mice and dosed for 14 days with erlotinib (100 mg/kg qd) or vehicle control. Statistical evaluation of percent tumor growth inhibition by repeated measures ANOVA was <t>done.</t> <t>H292,</t> <t>H358,</t> and <t>H441</t> were found to be sensitive to EGFR inhibition in vivo. No correlation between tumor growth rate and sensitivity to EGFR inhibition was observed. Solid bars, erlotinib dosing period. B, tumor cell lysates were evaluated for the expression of epithelial and mesenchymal proteins. Tumors were grown to a volume of f300 mm3, excised, and flash frozen in liquid nitrogen. Tumor tissues were pulverized while frozen, subjected to detergent lysis and SDS-PAGE as described, and immunoblots probed with antibodies to E-cadherin, h-catenin, Brk, fibronectin, and vimentin. Similar with in vitro results, E-cadherin expression was restricted to erlotinib-sensitive lines and vimentin to insensitive lines. Antibody to GAPDH was used as a loading control.
Cancer Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/Hep+G2/us12479842-2347-105-132
Average 99 stars, based on 1 article reviews
cancer cell lines - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

94
ATCC calu 6 cells
Figure 3. A, <t>NSCLC</t> lines were grown as s.c. xenografts in nu/nu mice and dosed for 14 days with erlotinib (100 mg/kg qd) or vehicle control. Statistical evaluation of percent tumor growth inhibition by repeated measures ANOVA was <t>done.</t> <t>H292,</t> <t>H358,</t> and <t>H441</t> were found to be sensitive to EGFR inhibition in vivo. No correlation between tumor growth rate and sensitivity to EGFR inhibition was observed. Solid bars, erlotinib dosing period. B, tumor cell lysates were evaluated for the expression of epithelial and mesenchymal proteins. Tumors were grown to a volume of f300 mm3, excised, and flash frozen in liquid nitrogen. Tumor tissues were pulverized while frozen, subjected to detergent lysis and SDS-PAGE as described, and immunoblots probed with antibodies to E-cadherin, h-catenin, Brk, fibronectin, and vimentin. Similar with in vitro results, E-cadherin expression was restricted to erlotinib-sensitive lines and vimentin to insensitive lines. Antibody to GAPDH was used as a loading control.
Calu 6 Cells, supplied by ATCC, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/Calu-6%3B+Anaplastic+Carcinoma%3B+Human/us07071332-1980-27-31
Average 94 stars, based on 1 article reviews
calu 6 cells - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

90
AstraZeneca ltd calu6
Panels (A-B) show fits of the model for <t>Calu6</t> and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.
Calu6, supplied by AstraZeneca ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/calu6/pmc04627780-209-8-35
Average 90 stars, based on 1 article reviews
calu6 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Oncolead Inc colo205
Panels (A-B) show fits of the model for <t>Calu6</t> and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.
Colo205, supplied by Oncolead Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/colo205/pmc10320480-57-36-20
Average 90 stars, based on 1 article reviews
colo205 - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

99
ATCC catalog htb 55 calu6 originated
Panels (A-B) show fits of the model for <t>Calu6</t> and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.
Catalog Htb 55 Calu6 Originated, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/Calu-3/us08021837-643-153-152
Average 99 stars, based on 1 article reviews
catalog htb 55 calu6 originated - by Bioz Stars, 2026-09
99/100 stars
  Buy from Supplier

94
Cell Signaling Technology Inc pvegfr 2 vegfr2 phosphoepitope western blot analysis
Panels (A-B) show fits of the model for <t>Calu6</t> and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.
Pvegfr 2 Vegfr2 Phosphoepitope Western Blot Analysis, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/Phospho-VEGF+Receptor+2+(Tyr951)+Antibody/10__1158_slash_1535___7163__mct___07___0142-116-4-20
Average 94 stars, based on 1 article reviews
pvegfr 2 vegfr2 phosphoepitope western blot analysis - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier

96
ATCC eleven lung cancer derived cell lines
Panels (A-B) show fits of the model for <t>Calu6</t> and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.
Eleven Lung Cancer Derived Cell Lines, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/HCC4006/pmc03388491-48-0-23
Average 96 stars, based on 1 article reviews
eleven lung cancer derived cell lines - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

calu 6  (DSMZ)
91
DSMZ calu 6
Panels (A-B) show fits of the model for <t>Calu6</t> and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.
Calu 6, supplied by DSMZ, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anaplastic+lung+cancer+calu+6/CALU-6/pm38160212-87-1-15
Average 91 stars, based on 1 article reviews
calu 6 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

Image Search Results


Figure 3. A, NSCLC lines were grown as s.c. xenografts in nu/nu mice and dosed for 14 days with erlotinib (100 mg/kg qd) or vehicle control. Statistical evaluation of percent tumor growth inhibition by repeated measures ANOVA was done. H292, H358, and H441 were found to be sensitive to EGFR inhibition in vivo. No correlation between tumor growth rate and sensitivity to EGFR inhibition was observed. Solid bars, erlotinib dosing period. B, tumor cell lysates were evaluated for the expression of epithelial and mesenchymal proteins. Tumors were grown to a volume of f300 mm3, excised, and flash frozen in liquid nitrogen. Tumor tissues were pulverized while frozen, subjected to detergent lysis and SDS-PAGE as described, and immunoblots probed with antibodies to E-cadherin, h-catenin, Brk, fibronectin, and vimentin. Similar with in vitro results, E-cadherin expression was restricted to erlotinib-sensitive lines and vimentin to insensitive lines. Antibody to GAPDH was used as a loading control.

Journal: Cancer Research

Article Title: Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non–Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition

doi: 10.1158/0008-5472.can-05-1058

Figure Lengend Snippet: Figure 3. A, NSCLC lines were grown as s.c. xenografts in nu/nu mice and dosed for 14 days with erlotinib (100 mg/kg qd) or vehicle control. Statistical evaluation of percent tumor growth inhibition by repeated measures ANOVA was done. H292, H358, and H441 were found to be sensitive to EGFR inhibition in vivo. No correlation between tumor growth rate and sensitivity to EGFR inhibition was observed. Solid bars, erlotinib dosing period. B, tumor cell lysates were evaluated for the expression of epithelial and mesenchymal proteins. Tumors were grown to a volume of f300 mm3, excised, and flash frozen in liquid nitrogen. Tumor tissues were pulverized while frozen, subjected to detergent lysis and SDS-PAGE as described, and immunoblots probed with antibodies to E-cadherin, h-catenin, Brk, fibronectin, and vimentin. Similar with in vitro results, E-cadherin expression was restricted to erlotinib-sensitive lines and vimentin to insensitive lines. Antibody to GAPDH was used as a loading control.

Article Snippet: The human NSCLC lines (H292, H358, H322, H441, A549, Calu6, H460, H1703, SW1573, Calu3, Colo699, H2122, A427, H1437, H1299, Hop92, and H23) were cultured in the appropriate American Type Culture Collection recommended supplemented media.

Techniques: Control, Inhibition, In Vivo, Expressing, Lysis, SDS Page, Western Blot, In Vitro

Panels (A-B) show fits of the model for Calu6 and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.

Journal: PLoS Computational Biology

Article Title: Oxygen-Driven Tumour Growth Model: A Pathology-Relevant Mathematical Approach

doi: 10.1371/journal.pcbi.1004550

Figure Lengend Snippet: Panels (A-B) show fits of the model for Calu6 and Colo205. The plots also include simulation of hypoxia and necrosis. (A) is a faster proliferating tumour model (Calu6) and (B) grows slightly slower (Colo205). (C-D) CD31 IHC staining in Calu6 and Colo205 respectively. (E) summary data of CD31 for both tumour models.

Article Snippet: We stained tissue sections of the following tumours: Calu6 (n = 8), Calu3 (n = 7), one squamous cell lung cancer explant (n = 28) and squamous cell lung clinical cancers (n = 12) from AstraZeneca databanks.

Techniques: Immunohistochemistry

(A) Growth curve fit for 4 explant models, 2 for squamous lung carcinoma and 2 for colorectal carcinoma. The xenografted cell line Calu3 shows very similar behaviour to explant models. (B) Comparison between Calu6 and Calu3 lung cell lines; a squamous lung cancer explant; and clinical tumour material analyses. The bar chart shows the proportions of microvessel density (MVD) in area (quantified from CD31), necrosis (quantified from Hematoxylin & Eosin staining) and stroma (alpha smooth muscle actin (αSMA) positive staining). (C) Images of the different tumour models stained for αSMA and counter-stained with hematoxylin.

Journal: PLoS Computational Biology

Article Title: Oxygen-Driven Tumour Growth Model: A Pathology-Relevant Mathematical Approach

doi: 10.1371/journal.pcbi.1004550

Figure Lengend Snippet: (A) Growth curve fit for 4 explant models, 2 for squamous lung carcinoma and 2 for colorectal carcinoma. The xenografted cell line Calu3 shows very similar behaviour to explant models. (B) Comparison between Calu6 and Calu3 lung cell lines; a squamous lung cancer explant; and clinical tumour material analyses. The bar chart shows the proportions of microvessel density (MVD) in area (quantified from CD31), necrosis (quantified from Hematoxylin & Eosin staining) and stroma (alpha smooth muscle actin (αSMA) positive staining). (C) Images of the different tumour models stained for αSMA and counter-stained with hematoxylin.

Article Snippet: We stained tissue sections of the following tumours: Calu6 (n = 8), Calu3 (n = 7), one squamous cell lung cancer explant (n = 28) and squamous cell lung clinical cancers (n = 12) from AstraZeneca databanks.

Techniques: Comparison, Staining

Parameter results ( k p and k R ′ ) for the ODM model in xenografts. Confidence intervals for each parameter are specified as well as the rank of the FIM (as a measure of the number of identifiable parameters), the collinearity index (Identifiable if γ <10), the condition number (Indentifiable if κ <1000) and the normalised residual. Cell lines denoted by * are unidentifiable and cell lines denoted by # are arguably identifiable.

Journal: PLoS Computational Biology

Article Title: Oxygen-Driven Tumour Growth Model: A Pathology-Relevant Mathematical Approach

doi: 10.1371/journal.pcbi.1004550

Figure Lengend Snippet: Parameter results ( k p and k R ′ ) for the ODM model in xenografts. Confidence intervals for each parameter are specified as well as the rank of the FIM (as a measure of the number of identifiable parameters), the collinearity index (Identifiable if γ <10), the condition number (Indentifiable if κ <1000) and the normalised residual. Cell lines denoted by * are unidentifiable and cell lines denoted by # are arguably identifiable.

Article Snippet: We stained tissue sections of the following tumours: Calu6 (n = 8), Calu3 (n = 7), one squamous cell lung cancer explant (n = 28) and squamous cell lung clinical cancers (n = 12) from AstraZeneca databanks.

Techniques: